20 June 2013
Keywords: novartis, vildagliptin, improves, pancreas, function, swiss, drugmaker
Article | 20 June 2005
Swiss drugmaker Novartis says that recent data presented at the annual meeting of the American Diabetes Association suggests that the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 June 2005
19 June 2013
© 2013 thepharmaletter.com